text: <unk>  is a Mucolytic enzyme that is FDA approved for the treatment of cystic fibrosis (CF) patients.   Common adverse reactions include voice alteration, pharyngitis, rash, laryngitis, chest pain, conjunctivitis, rhinitis, decrease in FVC of ≥10%, fever, and dyspnea.
option_0: Dornase alfa
option_1: Elosulfase alfa
option_2: Proteogenix
option_3: Sebelipase alfa
option_4: Asfotase alfa
option_5: Vestronidase alfa
option_6: Drotrecogin alfa
option_7: Haemopexin